We are live on ! Find out more
AP

AHL Partners Portfolio holdings

AUM $6.41B
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+23.14%
3 Year Est. Return
+67.81%
5 Year Est. Return
10 Year Est. Return
AUM
$1.94B
AUM Growth
+$647M
Cap. Flow
+$528M
Cap. Flow %
27.28%
Top 10 Hldgs %
6.97%
Holding
861
New
170
Increased
292
Reduced
269
Closed
129
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCR
26
DELISTED
CR Bard Inc.
BCR
$5.43M 0.28%
32,617
-5,986
-16% -$968K
PRA
27
DELISTED
ProAssurance
PRA
$5.43M 0.28%
120,304
+95,139
+378% +$4.35M
MGLN
28
DELISTED
Magellan Health Services, Inc.
MGLN
$5.42M 0.28%
90,357
-11,252
-11% -$664K
TRV icon
29
Travelers Companies
TRV
$77.7B
$5.42M 0.28%
51,178
-5,097
-9% -$515K
BDX icon
30
Becton Dickinson
BDX
$43.5B
$5.4M 0.28%
39,807
-10,232
-20% -$1.31M
CNC icon
31
Centene
CNC
$32.3B
$5.4M 0.28%
208,148
-55,648
-21% -$1.3M
EG icon
32
Everest Group
EG
$15B
$5.37M 0.28%
31,545
-250
-0.8% -$42.2K
RMD icon
33
ResMed
RMD
$28.9B
$5.37M 0.28%
95,717
-14,580
-13% -$761K
PDCO
34
DELISTED
Patterson Companies, Inc.
PDCO
$5.37M 0.28%
111,542
-20,142
-15% -$907K
EHC icon
35
Encompass Health
EHC
$11.1B
$5.36M 0.28%
175,153
-13,780
-7% -$430K
UNH icon
36
UnitedHealth
UNH
$393B
$5.35M 0.28%
52,959
-11,454
-18% -$1.09M
COR icon
37
Cencora
COR
$59.9B
$5.35M 0.28%
59,320
+38,347
+183% +$3.29M
EW icon
38
Edwards Lifesciences
EW
$49.4B
$5.35M 0.28%
251,886
-72,588
-22% -$1.46M
ZBH icon
39
Zimmer Biomet
ZBH
$17.7B
$5.34M 0.28%
48,474
-6,802
-12% -$717K
RNR icon
40
RenaissanceRe
RNR
$13.6B
$5.33M 0.28%
54,845
+2,730
+5% +$271K
CI icon
41
Cigna
CI
$74.2B
$5.33M 0.27%
51,745
-8,967
-15% -$884K
CB
42
DELISTED
CHUBB CORPORATION
CB
$5.31M 0.27%
51,317
-4,661
-8% -$464K
VAR
43
DELISTED
Varian Medical Systems, Inc.
VAR
$5.31M 0.27%
69,942
+10,861
+18% +$808K
OCR
44
DELISTED
OMNICARE INC
OCR
$5.31M 0.27%
72,745
-16,526
-19% -$1.12M
LH icon
45
Labcorp
LH
$23.2B
$5.29M 0.27%
57,098
-68
-0.1% -$6.01K
AFG icon
46
American Financial Group
AFG
$11.8B
$5.26M 0.27%
86,707
+443
+0.5% +$26.4K
MDAS
47
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
$5.26M 0.27%
266,350
+62,803
+31% +$1.28M
AIG icon
48
American International
AIG
$42.4B
$5.23M 0.27%
93,328
+4,814
+5% +$258K
STJ
49
DELISTED
St Jude Medical
STJ
$5.22M 0.27%
80,311
-7,613
-9% -$490K
AGO icon
50
Assured Guaranty
AGO
$3.73B
$5.21M 0.27%
200,456
-7,840
-4% -$189K

Similar funds

AHL Partners's Q4 2014 Portfolio in Review

As of Q4 2014, AHL Partners held 861 positions worth $1.94B, up 50% from $1.29B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

AHL Partners deployed $528M of net new capital in Q4 2014, opening 170 new positions and adding to 292 existing holdings. Its largest new stake was Herbalife: 245,614 shares worth $4.63M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was JetBlue, an estimated $4.3M trimmed.

  • AHL Partners's largest Q4 2014 buy was Herbalife: 245,614 shares worth $4.63M.
  • AHL Partners added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2014, an estimated $33.1M increase.
  • AHL Partners's biggest Q4 2014 reduction was JetBlue, cutting an estimated $4.3M.
  • AHL Partners fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q4 2014, selling an estimated $10.4M.
  • AHL Partners's ten largest holdings make up 7% of its $1.94B portfolio in Q4 2014.
  • AHL Partners opened 170 new positions and closed 129 in Q4 2014.
  • AHL Partners's portfolio value rose 50% quarter-over-quarter to $1.94B.

Based on AHL Partners's 13F filing for Q4 2014, filed 17 Feb 2015.